ESPE Abstracts

Introduction: The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions (GloBE-Reg, https://globe-reg.net/) project was launched in 2022 with the aim of supporting studies that focus on effectiveness and long-term safety of specific therapies. The project’s initial focus has been on recombinant human growth hormone therapy (rhGH) given that there are existing gaps in knowledge with the introdu...

Introduction: The clinical spectrum of nonfunctioning pituitary adenomas (NFPA), which are rare in childhood, varies from asymptomatic to hypopituitarism and/or severe compression-associated symptoms. We present the diagnosis, follow-up, and treatment of pediatric NFPA cases evaluated in a pituitary referral center.Methods: Data of patients aged <18 years and diagnosed with NFPA between 2002 and 2024 were reviewed ret...

Background/aim: HD is a life-threatening, but under-reported, disorder without accepted diagnostic criteria. We prospectively assessed the prevalence and severity of its 4 domains (sleep, appetite, temperature, thirst) in patients with congenital or acquired disorders, and their impact on quality of life (QoL).Methods: 66 patients (35M/31F) aged 12.4 &pm; 3.1 years, at risk of HD from tumours (n:36) or congenital maldeve...

Introduction: Pituitary gigantism patients are characterized by male predominance and large tumors that are difficult to control. In most cases, history, physical examination, and adjunctive biochemical, imaging, and/or molecular genetic testing will ultimately reveal the diagnosis.Methods: In this single-center study, demographic, clinical, endocrinological data of patients <19 years old who were followed up with the...

Background: Medulloblastoma accounts for about 10% of pediatric brain tumor, and about 60 to 100 cases occur in Japan per year. After tumor removal, chemotherapy and radiation therapy including craniospinal irradiation (CSI) are performed. Since the irradiation range of CSI includes hypothalamus, pituitary gland, thyroid, ovaries, and spine, it is known that endocrine deficiency and growth disorders are frequent as late effects. In this study, we aim to highli...

Background: Congenital combined pituitary hormone deficiency (CPHD) is a spectrum of disorders characterized by deficiencies in one or more pituitary hormones, ranging from isolated hormone deficiencies to complex hypopituitarism and severe midline developmental disorders. This study investigates the relationships between clinical features, laboratory findings, MRI results, and neurodevelopmental outcomes in patients with CPHD.Me...

Background: Micropenis may have various causes, like hormonal imbalances during fetal development, disorders affecting hormone production/action, and genetic factors. Determining the etiology may be challenging, especially in isolated cases and a thorough medical evaluation is typically necessary. The identification of genetic etiology is facilitated by the wide use of next-generation sequencing technologies. Here we report a patient presented with micropenis ...

Introduction: It is challenging to differentiate central diabetes insipidus (CDI) from Nephrogenic Diabetes Insipidus (NDI) or Primary Polydipsia (PP) in patients with polyuria-polydipsia syndrome, especially in the pediatric population. Despite its limited accuracy and low tolerance in children, the water deprivation test (WDT) is still used as a reference.Objectives: To review indications and outcomes of pediatric pati...

Objective: To investigate the role of serum anti-mullerian hormone (AMH) and inhibin-B (INHB) in central precocious puberty precocious puberty (CPP) and early and fast puberty (EFP).Methods: A total of 423 girls with CPP, EFP, premature thelarche (PT) and undeveloped healthy who were treated in our Hospital from October 2020 to December 2022 were collected. General data, sex hormones, AMH, INHB levels and gonad ultrasoun...